Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2003, No. 01
(2003; 12 pages) View the PDF document
Table of Contents
Open this folder and view contentsREGULATORY MATTERS
Open this folder and view contentsSAFETY OF MEDICINES
Open this folder and view contentsDRUGS OF CURRENT INTEREST
Open this folder and view contentsFEATURE
View the documentEVENTS & ANNOUNCEMENTS
 

WHO Pharmaceuticals Newsletter 2003, No. 01

EDITORIAL

This first issue of the newsletter for 2003 reaches you with many good wishes and hopes of further collaboration in raising awareness in drug safety and related issues. Several activities are being planned for 2003 to promote efforts in public health and pharmacovigilance programmes. In addition, the 8th international pharmacovigilance training course will be offered in Sweden, in May 2003 and the annual meeting of the national centres for pharmacovigilance will take place in December, in India. Details of the national centres’ meeting and the International Conference of Drug Regulatory Authorities (ICDRA) are on page 10.

In this issue you will find some reports and regulatory measures for nefazodone, a drug which is currently causing concern with reports of hepatotoxicity from around the world.

The feature article reflects the difficulties with terminologies in classifying some psychoactive substances as drugs of abuse. Clearly this is an area that will continue to evolve as issues of methodology, definitions and key terms are discussed and debated upon for a global consensus.

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014